Study to Evaluate Safety, Efficacy of Intralesional Injection of STP705 in Adults With Facial isSCC
NCT05421013
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
9
Enrollment
INDUSTRY
Sponsor class
Conditions
Facial isSCC
Interventions
DRUG:
STP705
Sponsor
Sirnaomics